from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3356c/folD

LFCtreatmentdescriptionclass of inhibitor

0.906

Amikacinug/mL Amikacintranslation

-0.239

Cap5-10ug/mL Capreomycintranslation

-1.012

Rox10-50 ug/mL Roxithromycintranslation

0.446

SM2-5 ug/mL Streptomycintranslation

-0.276

Tet5-10 ug/mL Tetracyclinetranslation

0.519

Rif0.2-5ug/mL Rifampicintranscription

-0.350

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.054

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.898

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.244

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.138

Clofazimine10-13 ug/mL Clofaziminerespiration

0.217

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.751

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.629

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.826

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.103

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.384

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.169

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.774

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.223

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.562

KCN5-20 ug/mL Potassium cyaniderespiration

0.880

NaN30.2-2 mM Sodium aziderespiration

0.449

Nigericin50 uM Nigericinrespiration

-0.984

TRC10-150 ug/mL Triclosanrespiration

-1.243

TRZ10-25 ug/mL Thioridazinerespiration

-0.497

Valinomycin0.5-10 uM Valinomycinrespiration

0.128

ZnSO42 mM ZnSO4respiration

0.509

menadione6-10 ug/mL Menadionerespiration

0.324

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.303

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.984

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.745

NRP_1Non-replicating persistence stage 1dosRassociated

0.543

Amp0.2mg/mL AmpicillincellWall

0.022

Cephalexin20-100 ug/mL CephalexincellWall

-0.226

Cerulenin0.32-5 ug/mL CerulenincellWall

0.070

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.523

EMB10-20 ug/mL EthambutolcellWall

0.278

Eta12-40 ug/mL EthionamidecellWall

-0.074

INH0.2-0.4 ug/mL IsoniazidcellWall

0.218

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.307

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.527

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.273

BZA0.12 mg/mL BenzamidearomaticAmides

-0.008

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.578

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.734

H2O24 mM hydrogen peroxideDNAdamaging

1.236

Levo10 ug/mL LevofloxacinDNAdamaging

-0.149

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.607

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.229

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.677

UVUV-irradiationDNAdamaging

1.421

ARP41-4 ug/mL Antitubercular compound ARP4?

0.147

Antimycin12.5-50 ug/mL Antimycin A?

1.017

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.626

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.229

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.348

PA8240.2-2 ug/mL PA-824?

-0.225

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.012

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.011

Verapamil50 uM Verapamil?

1.607

mercaptoethanol2 mM 2-Mercaptoethanol?

0.652

methoxatin10-20 ug/mL Methoxatin?